相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy of distant metastatic disease
D. Schadendorf et al.
ANNALS OF ONCOLOGY (2009)
Anti-CTLA4 Monoclonal Antibody Induced Sarcoidosis in a Metastatic Melanoma Patient
A. Eckert et al.
DERMATOLOGY (2009)
Multipeptide vaccination in cancer patients
Lorenzo Pilla et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Cutaneous melanoma in the era of molecular profiling
John F. Thompson et al.
LANCET (2009)
Anti-CTLA4 Antibody-Induced Lupus Nephritis.
Fouad Fadel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting telomerase for cancer therapeutics
J. W. Shay et al.
BRITISH JOURNAL OF CANCER (2008)
Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy
Y. Gao et al.
CANCER GENE THERAPY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Anti-CTLA4 monoclonal antibody ipilimumab in the treatment of metastatic melanoma: Recent findings
Marko Lens et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2008)
A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide
S. S. M. Ng et al.
CANCER GENE THERAPY (2007)
Telomeres and telomerase as targets for cancer therapy
S. Zimmermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single α-galactosylceramide treatment
Malcolm S. Duthie et al.
IMMUNOLOGY (2006)
Vaccination: role in metastatic melanoma
Lorenzo Pilla et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Antitumor activity of IFN-ℷ in murine tumor models
Atsuko Sato et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutaneous melanoma: available therapy for metastatic disease
Ahmad A. Tarhini et al.
DERMATOLOGIC THERAPY (2006)
Biochemotherapy in metastatic melanoma:: quo vadis?
P Queirolo et al.
MELANOMA RESEARCH (2005)
In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
JR Ortaldo et al.
JOURNAL OF IMMUNOLOGY (2005)
Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Medical progress - Management of cutaneous melanoma
H Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
AMM Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2004)
Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats
Y Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners
R Sun et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia
YC Linn et al.
LEUKEMIA & LYMPHOMA (2003)
Synergy between tumor immunotherapy and antiangiogenic therapy
S Nair et al.
BLOOD (2003)
Medical management of melanoma
CK Brown et al.
SURGICAL CLINICS OF NORTH AMERICA (2003)
Malignant melanoma: current state of primary and adjuvant treatment
TM Pawlik et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Booster effect of interleukin-2 on natural killer 1.1(+) cells stimulated by administration of macrophage colony-stimulating factor in mice
E Misawa et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -: Positive malignant melanoma through augmented NK activity and cytotoxic T-cell response
T Yajima et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy
A Scardino et al.
JOURNAL OF IMMUNOLOGY (2002)
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II cytokine working group trials
LE Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials
M Huncharek et al.
MELANOMA RESEARCH (2001)
Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft
PR Clark et al.
CELLULAR IMMUNOLOGY (2000)
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
B Minev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
SK Nair et al.
NATURE MEDICINE (2000)
CD4(+) V(alpha)14NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
H Ishikawa et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
